Long COVID/PASC

Advocacy

AAPM&R is Calling for a Comprehensive National Plan to Address the Needs of Millions Suffering from Long COVID

According to two recent publications from the Journal of the American Medical Association, ten to thirty percent of individuals who had COVID-19 reported at least one persistent symptom up to six months after the virus left their bodies. That means 3 to 10 million Americans are experiencing symptoms of Long COVID or Post-Acute Sequelae of SARS-CoV-2 infection (PASC), which are varied and ongoing, including neurological challenges, cognitive problems such as brain fog, shortness of breath, fatigue, pain, and mobility issues.

AAPM&R called on President Joe Biden and Congress to gear up for the next coronavirus crisis by preparing and implementing a comprehensive national plan focused on meeting the needs of millions of individuals suffering from the long-term symptoms of COVID-19, and help them regain quality of life and return to being active members of their communities. The plan must include a commitment to three major components:

  • Resources to build necessary infrastructure to meet this crisis
  • Equitable access to care for patients
  • Research to advance medical understanding of Long COVID

PM&R physicians are uniquely qualified to help guide the multidisciplinary effort needed to develop a plan for this crisis. As a specialty, physiatrists are investigators, team leaders and problem solvers. PM&R physicians see the whole patient AND the whole picture of the rehabilitation ecosystem. Physiatrists are exactly what this crisis needs. Learn more about our Multidisciplinary PASC Collaborative, launched in March 2021, which is working on quality improvement initiatives.

AAPM&R Advocacy, Healthcare Collaborations and Partnerships, and Customized Resources to Support PM&R During This Crisis

AAPM&R is working to ensure PM&R is part of the national conversation about healthcare amidst COVID-19 and advocating for the federal support, legislation, regulation relief and resources that physiatrists need now. One way we are doing this is through our partnerships and collaborations with other specialty societies. The Academy continuously works to represent PM&R through these collaborations, and it is through these partnerships that we are able to discuss and share a variety of resources with you that you critically need.

Stay Up-to-Date

AAPM&R Long COVID Consensus Guidance Statements Published on Diagnosing and Treating Long COVID Symptoms of Breathing Discomfort and Cognitive Symptoms

Dec 14, 2021

Today we released the next two parts in AAPM&R's series of consensus statements with practical guidance for clinicians treating patients suffering from breathing discomfort or cognitive symptoms, two common symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), or Long COVID. This is the only multidisciplinary collaborative consensus guidance for Long COVID symptoms and it comes from AAPM&R’s PASC Collaborative.

Long COVID is a condition that occurs in individuals who have had COVID-19 and report at least one persistent symptom after acute illness. An estimated three to thirteen million Americans have symptoms of Long COVID, based on data from the Journal of the American Medical Association and our Long COVID Dashboard. Long COVID symptoms are varied and ongoing and include neurological challenges, cognitive symptoms such as brain fog, respiratory issues, fatigue, pain and mobility issues.

“Long COVID is a long-term public health issue,” said Benjamin Abramoff, MD, MS, FAAPMR, Co-Chair of the Multidisciplinary PASC Collaborative, convened by AAPM&R to address the pressing need for guidance in caring for patients with Long COVID. “Physical medicine and rehabilitation (PM&R) physicians are uniquely qualified to help guide the multidisciplinary effort needed to develop Long COVID diagnosis and treatment guidance.”

Our PASC Collaborative published these consensus guidance statements as a peer-reviewed manuscript in the PM&R Journal.

The severity of Long COVID respiratory issues appear to be associated with the patient’s acute COVID-19 illness. Shortness of breath and breathing discomfort may affect Long COVID patients with an initial mild case of COVID-19. Of note, breathing discomfort can be misdiagnosed in some groups. Patients with darker skin pigmentation may have inconclusive pulse oximetry readings, and clinicians should consider additional workup for lung disease and pulmonology referral. While pregnant people may experience shortness of breath due to pregnancy, pregnant Long COVID patients should be given prompt evaluation if experiencing new shortness of breath.

Cognitive symptoms can range from “brain fog” to difficulty completing daily activities or loss of concentration. Women may experience cognitive symptoms with Long COVID more frequently than men.

“New research shows that patients with strong interpersonal support systems and good sleep hygiene respond better to Long COVID therapies, and these activities are especially important in rehabilitation for cognitive symptoms,” Monica Verduzco-Gutierrez, MD, FAAPMR, co-author of the breathing discomfort and cognitive symptoms guidance statements said. “We must make sure that rehabilitation for all patients with Long COVID symptoms is individually tailored and moves at the patient’s own pace rather than a set timetable.”

Rehabilitation for Long COVID cognitive symptoms follows established techniques used for patients with concussion or traumatic brain injury. Programs to rehabilitate breathing issues may include progressive exercise two to three times a week for two to three months, guided breathing therapy, oxygen management, energy conservation and pacing, medication management, nutritional guidance, emotional support and education. Inhaled therapies and oral glucocorticoids used to treat chronic breathing issues like asthma, do not commonly improve symptoms or pulmonary function and may be accompanied by side effects.

The AAPM&R PASC Collaborative released its first consensus guidance on fatigue in August. Additional consensus guidance statements on cardiovascular complications, autonomic disorders, mental health, pediatrics and neurology will be published on a rolling basis.

Since the beginning of 2021, we have undertaken comprehensive efforts to support our call for a national plan to address PASC and the millions of Americans it affects. Learn more about the consensus guidance methodology, the Long COVID Dashboard and AAPM&R’s Long COVID Call to Action.